Live
FierceBiotechBioVie plans $20M IPO for spinout tasked with developing liver disease drugFierceBiotechR1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatmentEndpoints NewsRoche, Nvidia to build largest 'AI factory' in pharmaEndpoints NewsNew renal disease biotech R1 Therapeutics nabs $77.5M for Phase 2bEndpoints NewsJ&J pulls out of NYC biotech incubator as it shrinks locationsEndpoints NewsChina mRNA therapy startup Innorna to test gout treatment in USBioPharma DiveR1 starts up with $78M, aiming for a better kidney drugWatersLondon Co. of Virginia Has $166.65 Million Position in Waters Corporation $WAT - MarketBeatRoche MediaRoche scales NVIDIA tie-up with large AI factory push - The PharmaletterThermo FisherGotham Asset Management LLC Reduces Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeatAgilentCSM Advisors LLC Has $1.32 Million Position in Agilent Technologies, Inc. $A - MarketBeatAgilentAgilent Technologies, Inc. $A Shares Purchased by California Public Employees Retirement System - MarketBeat
FierceBiotech Mar 17, 2026

BioVie plans $20M IPO for spinout tasked with developing liver disease drug

BioVie plans $20M IPO for spinout tasked with developing liver disease drug

Original
Body unavailable. Use the original source.

Directory

59 All